CD8A and neoplasm: Moreover, combination of the vaccination and wild-type CD8+ T cells specific for tumor antigen gp33 (P14) exhibited longer protective effects than the combination of vaccination and Tcf7 −/− P14 cells13, suggesting that extended tumor control depended on TCF1.